MEDROL Side Effects

7021245-0 | Gouty Tophus
on Sep 22, 2010 Female patient from JAPAN , 34 years of age, was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: gouty tophus. Medrol dosage: 6 Mg/4 Mg In Alternate Day. During the same period patient was treated with ONE ALPHA (Unk) (View One-alpha Review and One-alpha Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), OMEPRAL (Unk) (View Omepral Review and Omepral Label ), PERSANTIN (Unk) (View Persantin Review and Persantin Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), ADETPHOS (Unk) (View Adetphos Review and Adetphos Label ), MECOBALAMIN (Unk) (View Mecobalamin Review and Mecobalamin Label ), ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ).

7020874-8 | Cutaneous Leishmaniasis
Patient was taking Medrol (View Usage). Patient had the following side effects: cutaneous leishmaniasis on Sep 23, 2010 from ITALY Additional patient health information: Male patient , 48 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with METHOTREXATE (10 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), HUMIRA (40 Mg, Every 2 Weeks) (View Humira Review and Humira Label ), TRIATEC (2.5 Mg, 1x/day) (View Triatec Review and Triatec Label ), CARDURA (2 Mg, 1x/day) (View Cardura Review and Cardura Label ), CARDIOASPIRINA (100 Mg, 1x/day) (View Cardioaspirina Review and Cardioaspirina Label ), LEDERFOLIN (7.5 Mg, Weekly) (View Lederfolin Review and Lederfolin Label ), LANSOPRAZOLE (30 Mg, 1x/day) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

7019624-0 | Abdominal Distension, Confusional State, Depression, Dizziness, Dyspnoea, Headache, Heart Rate Increased, Hepatomegaly, Hypertension
Adverse event was reported on Sep 28, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 4mg 1 Daily 7 Days) was diagnosed with infected bites and. Location: UNITED STATES , weighting 238.0 lb, After Medrol was administered, patient had the following side effects: abdominal distension, confusional state, depression (What is depression?), dizziness (What is dizziness?), dyspnoea, headache (What is headache?), heart rate increased, hepatomegaly, hypertension.

7013644-8 | Cutaneous Leishmaniasis
on Sep 13, 2010 Male patient from ITALY , 48 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous leishmaniasis. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with METHOTREXATE (10 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), HUMIRA (40 Mg, Every 2 Weeks) (View Humira Review and Humira Label ), TRIATEC (2.5 Mg, 1x/day) (View Triatec Review and Triatec Label ), CARDURA (2 Mg, 1x/day) (View Cardura Review and Cardura Label ), CARDIOASPIRINA (100 Mg, 1x/day) (View Cardioaspirina Review and Cardioaspirina Label ), LEDERFOLIN (7.5 Mg, Weekly) (View Lederfolin Review and Lederfolin Label ), LANSOPRAZOLE (30 Mg, 1x/day) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.


7006061-8 | Endometriosis, Osteoporosis, Vaginal Discharge, Vaginal Haemorrhage
on Sep 09, 2010 Female patient from COLOMBIA , 40 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pain (What is pain?) and was treated with Medrol (View Usage). Patient had the following side effects: endometriosis (What is endometriosis?), osteoporosis (What is osteoporosis?), vaginal discharge, vaginal haemorrhage. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with METHOTREXATE (2.5 Mg, 3 Tablets Per Day) (View Methotrexate Review and Methotrexate Label ), ENBREL (50 Mg, Weekly) (View Enbrel Review and Enbrel Label ), IBUPROFEN (800 Mg, 1x/day) (View Ibuprofen Review and Ibuprofen Label ).

6970971-8 | Gastric Ulcer, Peritonitis
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: gastric ulcer, peritonitis on Sep 01, 2010 from ITALY Additional patient health information: Female patient , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Medrol dosage: 4 Mg, X/day. During the same period patient was treated with DICLOREUM (100 Mg, X/day) (View Dicloreum Review and Dicloreum Label ), METHOTREXATE ^WYETH LEDERLE^ (15 Mg, Weekly) (View Methotrexate ^wyeth Lederle^ Review and Methotrexate ^wyeth Lederle^ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM CARBONATE/COLECALCIFEROL (View Calcium Carbonate/colecalciferol Review and Calcium Carbonate/colecalciferol Label ). Patient was hospitalized.

6964670-6 | Blood Pressure Increased, Choking Sensation, Dysphagia, Dyspnoea, Tachycardia
Adverse event was reported on Aug 27, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 18 Mg, 3x/day) was diagnosed with lichen planus, prophylaxis and. Location: GREECE , 49 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, choking sensation, dysphagia, dyspnoea, tachycardia. During the same period patient was treated with XANAX (1/4 Of 0.25 Mg Tablet, Unk) (View Xanax Review and Xanax Label ), PARIET (1 Df, Unk) (View Pariet Review and Pariet Label ).

6962770-8 | Hepatic Neoplasm Malignant Recurrent
on Aug 04, 2010 Male patient from FINLAND , 54 years of age, weighting 123.5 lb, was diagnosed with immunosuppression, prophylaxis against transplant rejection, hypertension and was treated with Medrol (View Usage). Patient had the following side effects: hepatic neoplasm malignant recurrent. Medrol dosage: Unk. During the same period patient was treated with MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ).

6944490-9 | Rash Morbilliform
on Aug 23, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with meningoencephalitis herpetic and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: rash morbilliform. Medrol dosage: 16 Mg, 1x/day. During the same period patient was treated with TEGRETOL (200 Mg, 2x/day) (View Tegretol Review and Tegretol Label ), CEFIXIME (Unk) (View Cefixime Review and Cefixime Label ), ZOVIRAX (800 Mg, 4x/day) (View Zovirax Review and Zovirax Label ), LITHIUM (Unk) (View Lithium Review and Lithium Label ), EFFEXOR (Unk) (View Effexor Review and Effexor Label ), ALFUZOSIN (Unk) (View Alfuzosin Review and Alfuzosin Label ), ACICLOVIR (Unk) (View Aciclovir Review and Aciclovir Label ). Patient was hospitalized.

6931864-5 | Cutaneous Leishmaniasis
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous leishmaniasis on Aug 12, 2010 from ITALY Additional patient health information: Male patient , 48 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with METHOTREXATE (15 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), HUMIRA (40 Mg, Cyclic) (View Humira Review and Humira Label ). Patient was hospitalized.

6923115-2 | Chest Discomfort, Heart Rate Increased, Inner Ear Inflammation, Malaise, Nasopharyngitis, Oropharyngeal Pain, Productive Cough
Adverse event was reported on Aug 06, 2010 by a Male patient taking Medrol (View Usage) (Dosage: 8 Mg, 1x/day) was diagnosed with hypersensitivity, infection (What is infection?) and. Location: PHILIPPINES , 35 years of age, weighting 147.7 lb, Patient had the following side effects: chest discomfort, heart rate increased, inner ear inflammation, malaise, nasopharyngitis, oropharyngeal pain, productive cough. During the same period patient was treated with AUGMENTIN '125' (375 Mg, 2x/day) (View Augmentin '125' Review and Augmentin '125' Label ).

6910705-6 | Metastases To Bone
on Jul 29, 2010 Female patient from BELGIUM , 73 years of age, weighting 99.21 lb, was diagnosed with dermatomyositis and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: metastases to bone. Medrol dosage: 2 Mg, 1x/day. During the same period patient was treated with ASAFLOW (80 Mg, 1x/day) (View Asaflow Review and Asaflow Label ), LANOXIN (0.25 Mg, 1x/day) (View Lanoxin Review and Lanoxin Label ), ALENDRONATE SODIUM (70 Mg, Weekly) (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

6908616-5 | Cutaneous Leishmaniasis
on Jul 30, 2010 Male patient from ITALY , 48 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous leishmaniasis. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with METHOTREXATE (15 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), HUMIRA (40 Mg, Cyclic) (View Humira Review and Humira Label ). Patient was hospitalized.

6900566-3 | Gastric Ulcer, Peritonitis
Patient was taking Medrol (View Usage). Patient had the following side effects: gastric ulcer, peritonitis on Jul 30, 2010 from ITALY Additional patient health information: Female patient , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Medrol dosage: 4 Mg, X/day. During the same period patient was treated with DICLOREUM (100 Mg, X/day) (View Dicloreum Review and Dicloreum Label ), METHOTREXATE ^WYETH LEDERLE^ (15 Mg, Weekly) (View Methotrexate ^wyeth Lederle^ Review and Methotrexate ^wyeth Lederle^ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM CARBONATE/COLECALCIFEROL (View Calcium Carbonate/colecalciferol Review and Calcium Carbonate/colecalciferol Label ). Patient was hospitalized.

6881797-8 | Lung Neoplasm Malignant
Adverse event was reported on Jul 20, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 4 Mg, 1x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteopenia, hypertension and. Location: GREECE , 65 years of age, After Medrol was administered, patient had the following side effects: lung neoplasm malignant. During the same period patient was treated with METHOTREXATE (10 Mg, 1x Weekly) (View Methotrexate Review and Methotrexate Label ), HUMIRA (40 Mg, Every 14 Days) (View Humira Review and Humira Label ), IDEOS (1 Df, 1x/day) (View Ideos Review and Ideos Label ), PACTENS (5 Mg (0.5 Of 10 Mg), 1x/day) (View Pactens Review and Pactens Label ). Patient was hospitalized.

6843957-1 | Ovarian Cancer
on Jul 08, 2010 Female patient from ITALY , 37 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer. Medrol dosage: 4 Mg, 1x/day. During the same period patient was treated with ENBREL (50 Mg, Weekly) (View Enbrel Review and Enbrel Label ), PANTORC (20 Mg, Unk) (View Pantorc Review and Pantorc Label ), COLECALCIFEROL (25 Drops) (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6831310-6 | Anti-hbc Antibody Positive, Hepatitis B E Antigen Positive, Hepatitis B Surface Antigen Positive, Hypotonia
on Jul 01, 2010 Female patient from CHINA , 48 years of age, was treated with Medrol (View Usage). Patient had the following side effects: anti-hbc antibody positive, hepatitis b e antigen positive, hepatitis b surface antigen positive, hypotonia. Medrol dosage: 32 Mg, Unk.

6810485-9 | Anti-hbc Antibody Positive, Hepatitis B E Antigen Positive, Hepatitis B Surface Antigen Positive, Hypotonia
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: anti-hbc antibody positive, hepatitis b e antigen positive, hepatitis b surface antigen positive, hypotonia on Jun 22, 2010 from CHINA Additional patient health information: Female patient , 48 years of age, . Medrol dosage: 32 Mg, Unk.

6808353-1 | Burning Sensation
Adverse event was reported on May 27, 2009 by a Female patient taking Medrol (View Usage) (Dosage: ) . Location: UNITED STATES , 35 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation.

6807563-7 | Dysgeusia
on Jan 21, 2009 Female patient from UNITED STATES , weighting 120.3 lb, was diagnosed with facial palsy and was treated with Medrol (View Usage). Patient had the following side effects: dysgeusia. Medrol dosage: .

6807306-7 | Heart Rate Irregular
on Aug 22, 2008 Female patient from UNITED STATES , 61 years of age, was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: heart rate irregular. Medrol dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6806765-3 | Erythema, Flushing, Hypertension, Insomnia, Mood Swings, Rash
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, flushing, hypertension, insomnia, mood swings, rash (What is rash?) on Jul 11, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with injury and. Medrol dosage: .

6806684-2 | Fatigue, Feeling Jittery, Nausea
Adverse event was reported on Apr 01, 2008 by a Female patient taking Medrol (View Usage) (Dosage: ) was diagnosed with tinnitus (What is tinnitus?), ear discomfort and. Location: UNITED STATES , weighting 142.3 lb, Patient had the following side effects: fatigue, feeling jittery, nausea (What is nausea?). During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ).

6806547-2 | Sleep Disorder
on Apr 30, 2008 Male patient from UNITED STATES , weighting 165.3 lb, was diagnosed with neuralgia and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: sleep disorder (What is sleep disorder?). Medrol dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ), PANCREATIN (View Pancreatin Review and Pancreatin Label ).

6806522-8 | Headache, Hypertension, Mood Swings
on May 16, 2008 Male patient from UNITED STATES , weighting 150.3 lb, was diagnosed with joint injury and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypertension, mood swings. Medrol dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6802091-7 | Pruritus
Patient was taking Medrol (View Usage). Patient had the following side effects: pruritus on Nov 27, 2007 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with anaemia and. Medrol dosage: . During the same period patient was treated with SLOW FE (View Slow-fe Review and Slow-fe Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ALLEGRA (View Allegra Review and Allegra Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), COMBIVENT (View Combivent Review and Combivent Label ), CRESTOR (View Crestor Review and Crestor Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6794477-4 | Anti-hbc Antibody Positive, Hepatitis B E Antigen Positive, Hepatitis B Surface Antigen Positive, Hypotonia
Adverse event was reported on Jun 18, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 32 Mg, Unk) . Location: CHINA , 48 years of age, After Medrol was administered, patient had the following side effects: anti-hbc antibody positive, hepatitis b e antigen positive, hepatitis b surface antigen positive, hypotonia.

6784498-X | Respiratory Tract Infection
on Jun 17, 2010 Male patient from BELGIUM , 72 years of age, weighting 193.8 lb, was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory tract infection. Medrol dosage: 16 Mg, 1x/day. During the same period patient was treated with ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), GLICLAZIDE (Unk) (View Gliclazide Review and Gliclazide Label ), ASAFLOW (Unk) (View Asaflow Review and Asaflow Label ), DIOVANE (Unk) (View Diovane Review and Diovane Label ), FLECAINIDE ACETATE (Unk) (View Flecainide Acetate Review and Flecainide Acetate Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (Unk) (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), NEORECORMON ^BOEHRINGER MANNHEIM^ (Unk) (View Neorecormon ^boehringer Mannheim^ Review and Neorecormon ^boehringer Mannheim^ Label ), BIOFENAC ^UCB^ (Unk) (View Biofenac ^ucb^ Review and Biofenac ^ucb^ Label ). Patient was hospitalized.

6778997-4 | Squamous Cell Carcinoma Of The Cervix
on Jun 09, 2010 Female patient from FRANCE , 63 years of age, was treated with Medrol (View Usage). Patient had the following side effects: squamous cell carcinoma of the cervix. Medrol dosage: Unk. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), PLAQUENIL (Unk) (View Plaquenil Review and Plaquenil Label ), THALIDOMIDE (Unk) (View Thalidomide Review and Thalidomide Label ), PROTOPIC (Unk) (View Protopic Review and Protopic Label ), MINOCYCLINE (Unk) (View Minocycline Review and Minocycline Label ), DISULONE (Unk) (View Disulone Review and Disulone Label ), REMICADE (Unk) (View Remicade Review and Remicade Label ). Patient was hospitalized.

6772756-4 | Histiocytosis Haematophagic
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: histiocytosis haematophagic on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Medrol dosage: Unk. During the same period patient was treated with METHOTREXATE SODIUM (Unk) (View Methotrexate Sodium Review and Methotrexate Sodium Label ).

6763888-5 | Body Temperature Decreased
Adverse event was reported on Jun 04, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 4 Mg, 1x/day) was diagnosed with pyrexia and. Location: JAPAN , 50 years of age, Patient experienced the following unwanted or unexpected effects: body temperature decreased.

6762942-1 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Respiratory Tract Infection
on May 31, 2010 Female patient from GREECE , 55 years of age, weighting 94.80 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?) and was treated with Medrol (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated, respiratory tract infection. Medrol dosage: . During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), ACTONEL (View Actonel Review and Actonel Label ).

6759297-5 | Muscle Atrophy, Nausea, Tremor, Vertigo
on May 26, 2010 Male patient from SOUTH AFRICA , 70 years of age, was diagnosed with nephritis, red blood cell count decreased and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: muscle atrophy, nausea (What is nausea?), tremor, vertigo. Medrol dosage: 48 Mg, 1x/day. During the same period patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (2 Drips Per Day For 3 Days) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), TAMSULOSIN (Unk) (View Tamsulosin Review and Tamsulosin Label ), EPREX (Unk) (View Eprex Review and Eprex Label ).

6759268-9 | White Blood Cell Count Increased
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count increased on Jun 02, 2010 from CHINA Additional patient health information: Female patient , 17 years of age, was diagnosed with colitis ulcerative and. Medrol dosage: 40 Mg, 1x/day. Patient was hospitalized.

6759225-2 | Disseminated Intravascular Coagulation, Sepsis, Septic Shock
Adverse event was reported on May 26, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 6 Mg, 1x/day) was diagnosed with behcet's syndrome (What is behcet's syndrome?) and. Location: JAPAN , 55 years of age, Patient had the following side effects: disseminated intravascular coagulation, sepsis (What is sepsis?), septic shock.

6756255-1 | Faecaloma
on May 25, 2010 Male patient from BELGIUM , 83 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, constipation (What is constipation?) and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: faecaloma. Medrol dosage: Unk. During the same period patient was treated with LENALIDOMIDE (Unk) (View Lenalidomide Review and Lenalidomide Label ), VELCADE (1 Mg/m2, Unk) (View Velcade Review and Velcade Label ), ASAFLOW (80 Mg, 1x/day) (View Asaflow Review and Asaflow Label ), MEGLUMINE AMIDOTRIZOATE (Unk) (View Meglumine Amidotrizoate Review and Meglumine Amidotrizoate Label ). Patient was hospitalized.

6752036-3 | Blood Glucose Increased, Diarrhoea, Oedema Peripheral, Weight Decreased
on May 27, 2010 Male patient from UNITED STATES , weighting 399.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), diabetes mellitus, blood cholesterol increased, hypertension and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, diarrhoea, oedema peripheral, weight decreased. Medrol dosage: Unk. During the same period patient was treated with HUMIRA (40 Mg, 1 In 2 Wk) (View Humira Review and Humira Label ), METFORMIN HYDROCHLORIDE (Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LEFLUNOMIDE (Unk) (View Leflunomide Review and Leflunomide Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), TRAMADOL (Unk) (View Tramadol Review and Tramadol Label ), TYLOX (Unk) (View Tylox Review and Tylox Label ), DICLOFENAC SODIUM (Unk) (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6746316-5 | Nasopharyngitis
Patient was taking Medrol (View Usage). Patient had the following side effects: nasopharyngitis on May 18, 2010 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Medrol dosage: 5 Mg, 1x/day. During the same period patient was treated with ABATACEPT (500 Mg, Monthly) (View Abatacept Review and Abatacept Label ), GASMOTIN (Unk) (View Gasmotin Review and Gasmotin Label ), KOLANTYL (Unk) (View Kolantyl Review and Kolantyl Label ), ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), MOBIC (Unk) (View Mobic Review and Mobic Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6744432-5 | Bronchopneumonia
Adverse event was reported on May 24, 2010 by a Male patient taking Medrol (View Usage) (Dosage: 32 Mg Per Day) was diagnosed with colitis ulcerative and. Location: ITALY , 44 years of age, weighting 158.7 lb, After Medrol was administered, patient had the following side effects: bronchopneumonia. Patient was hospitalized.

6741320-5 | Angina Pectoris, Flushing, Hypertension
on May 19, 2010 Female patient from FRANCE , 44 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, flushing, hypertension. Medrol dosage: 50 Mg, 2x/day. During the same period patient was treated with HERCEPTIN (600 Mg, 1x/day) (View Herceptin Review and Herceptin Label ). Patient was hospitalized.

6738744-9 | Bone Formation Decreased
on May 13, 2010 Female patient from GREECE , 15 years of age, weighting 127.9 lb, was diagnosed with asthma (What is asthma?) and was treated with Medrol (View Usage). Patient had the following side effects: bone formation decreased. Medrol dosage: 8 Mg, 1x/day. During the same period patient was treated with FLIXOTIDE ^GLAXO^ (View Flixotide ^glaxo^ Review and Flixotide ^glaxo^ Label ).

6734987-9 | Bronchopneumonia
Patient was taking Medrol (View Usage). After Medrol was administered, patient had the following side effects: bronchopneumonia on May 11, 2010 from ITALY Additional patient health information: Male patient , 44 years of age, weighting 158.7 lb, was diagnosed with colitis ulcerative and. Medrol dosage: 32 Mg, X/day. Patient was hospitalized.

6728573-4 | Nasopharyngitis
Adverse event was reported on May 07, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 5 Mg, 1x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: nasopharyngitis. During the same period patient was treated with ABATACEPT (500 Mg, Monthly) (View Abatacept Review and Abatacept Label ), GASMOTIN (Unk) (View Gasmotin Review and Gasmotin Label ), KOLANTYL (Unk) (View Kolantyl Review and Kolantyl Label ), ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), MOBIC (Unk) (View Mobic Review and Mobic Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6726011-9 | Bone Formation Decreased
on May 03, 2010 Female patient from GREECE , 15 years of age, weighting 127.9 lb, was diagnosed with asthma (What is asthma?) and was treated with Medrol (View Usage). Patient had the following side effects: bone formation decreased. Medrol dosage: 8 Mg, 1x/day. During the same period patient was treated with FLIXOTIDE ^GLAXO^ (View Flixotide ^glaxo^ Review and Flixotide ^glaxo^ Label ).

6724536-3 | Chest Pain
on May 10, 2010 Female patient from CHINA , 50 years of age, was diagnosed with uveitis and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: chest pain (What is chest pain?). Medrol dosage: 8 Mg, Daily.

6704139-7 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: reversible posterior leukoencephalopathy syndrome on Apr 26, 2010 from JAPAN Additional patient health information: Female patient , child 7 years of age, weighting 50.71 lb, was diagnosed with pain (What is pain?) and. Medrol dosage: 1.5 Mg/kg, 1x/day. During the same period patient was treated with SOLU MEDROL (30 Mg/kg, Unk) (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), IBRUPROFEN (30-45 Mg/kg/day, 3 Times A Day) (View Ibruprofen Review and Ibruprofen Label ).

6697303-7 | Hypertension, Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Apr 16, 2010 by a Female patient taking Medrol (View Usage) (Dosage: 1.5 Mg/kg, 1x/day) was diagnosed with pain (What is pain?) and. Location: JAPAN , child 7 years of age, weighting 50.71 lb, Patient had the following side effects: hypertension, reversible posterior leukoencephalopathy syndrome. During the same period patient was treated with SOLU MEDROL (30 Mg/kg, Unk) (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), IBRUPROFEN (30-45 Mg/kg/day, 3 Times A Day) (View Ibruprofen Review and Ibruprofen Label ).

6694306-3 | Arthralgia, Myalgia, Neuropathy Peripheral, Pyrexia
on Apr 19, 2010 Male patient from FRANCE , 35 years of age, weighting 176.4 lb, was diagnosed with pneumocystis jiroveci pneumonia, prurigo and was treated with Medrol (View Usage). After Medrol was administered, patient had the following side effects: arthralgia, myalgia, neuropathy peripheral, pyrexia. Medrol dosage: Unk. During the same period patient was treated with TRUVADA (Unk) (View Truvada Review and Truvada Label ), REYATAZ (Unk) (View Reyataz Review and Reyataz Label ), NORVIR (Unk) (View Norvir Review and Norvir Label ), BACTRIM (Unk) (View Bactrim Review and Bactrim Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ). Patient was hospitalized.

6689944-8 | Asthenia, Nasopharyngitis
on Apr 13, 2010 Female patient from JAPAN , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Medrol (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, nasopharyngitis. Medrol dosage: 5 Mg, 1x/day. During the same period patient was treated with ABATACEPT (500 Mg, Monthly) (View Abatacept Review and Abatacept Label ), GASMOTIN (Unk) (View Gasmotin Review and Gasmotin Label ), KOLANTYL (Unk) (View Kolantyl Review and Kolantyl Label ), ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), MOBIC (Unk) (View Mobic Review and Mobic Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6673151-9 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Medrol (View Usage). Patient had the following side effects: reversible posterior leukoencephalopathy syndrome on Mar 31, 2010 from JAPAN Additional patient health information: Female patient , child 7 years of age, weighting 50.71 lb, was diagnosed with pain (What is pain?) and. Medrol dosage: 1.5 Mg/kg, 1x/day. During the same period patient was treated with SOLU MEDROL (30 Mg/kg, Twice) (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), IBUPROFEN (30mg/kg) (View Ibuprofen Review and Ibuprofen Label ).